about
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.A phase 0 trial of riluzole in patients with resectable stage III and IV melanomaThe Akt signaling pathway: an emerging therapeutic target in malignant melanoma.The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
New ideas for therapy in ALS.
@en
New ideas for therapy in ALS.
@nl
type
label
New ideas for therapy in ALS.
@en
New ideas for therapy in ALS.
@nl
prefLabel
New ideas for therapy in ALS.
@en
New ideas for therapy in ALS.
@nl
P1476
New ideas for therapy in ALS.
@en
P2860
P356
10.1080/14660820510035379
P577
2005-03-01T00:00:00Z